Prolonged incubation with Metformin decreased angiogenic potential in human bone marrow mesenchymal stem cells
Open Access
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 108, 1328-1337
Abstract
No abstract availableKeywords
Funding Information
- Tabriz University of Medical Sciences
This publication has 23 references indexed in Scilit:
- Paradoxic effects of metformin on endothelial cells and angiogenesisCarcinogenesis, 2014
- Low Concentrations of Metformin Selectively Inhibit CD133+ Cell Proliferation in Pancreatic Cancer and Have Anticancer ActionPLOS ONE, 2013
- Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasisProceedings of the National Academy of Sciences, 2012
- Insulin Resistance and Type 2 DiabetesDiabetes, 2012
- Oleic acid inhibits stearic acid-induced inhibition of cell growth and pro-inflammatory responses in human aortic endothelial cellsJournal of Lipid Research, 2010
- Improved assessment of laser-induced choroidal neovascularizationMicrovascular Research, 2010
- Maternal Circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ Progenitor Cells Increase During Normal Pregnancy but Are Reduced in Women With PreeclampsiaReproductive Sciences, 2010
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cellsJournal of Pharmacy and Pharmacology, 2008
- Differential protective effects of palmitoleic acid and cAMP on caspase activation and cell viability in pancreatic β-cells exposed to palmitateApoptosis, 2006